Surprisingly, a pretty nice yearly update. I was also surprised to see the revenue increase by as much as it has. It reminds me of ~3 years ago when they claimed they would have 3-4x revenue and have a positive bottom line, at least one of those seems to be true. However, and a pretty big however for most investors, deciding to not be SEC compliant is a huge negative. I understand their reasoning, but this will not attract new investors no matter what successes they have business/medical wise, and no new investors means the pps will remain stagnant with little hope for an organic rise in pps. So in the end, we're left exactly where we were last year/year before, which is clinging to a straw of hope for a larger company to actually take notice and acquire them, because that is officially the only way the pps goes up here. So based on that, I honestly think a buyout around the 20 cent mark would be very fair to all involved, as 4-5m is not a huge risk for a larger company and it would reward shareholders here too.
